Brexpiprazole for schizophrenia and as adjunct for major depressive disorder

Adjunctive Brexpiprazole: A Review in Major Depressive Disorder

Psychopharmacology Update - ppt download

What you need to know about Rexulti (Brexpiprazole)

Brexpiprazole-impurities

Brexpiprazole: A New Treatment Option for Schizophrenia - Innovations in Clinical Neuroscience

Table 1 from Brexpiprazole (Rexulti): A New Monotherapy for Schizophrenia and Adjunctive Therapy for Major Depressive Disorder.

Brexpiprazole: A New Treatment Option for Schizophrenia and Major Depressive Disorder - Marija Markovic, Alyssa Gallipani, Krina H. Patel, Megan Maroney, 2017

Aripiprazole, brexpiprazole, and cariprazine: Not all the same: Understanding the key differences among these agents can help inform treatment decisions - Document - Gale Academic OneFile

Frontiers Case report: Effectiveness of brexpiprazole and esketamine/ketamine combination: A novel therapeutic strategy in five cases of treatment-resistant depression

מחקרים על ריקסלטי כטיפול אוגמנטציה בדיכאון (MDD)

Brexpiprazole and cariprazine: distinguishing two new atypical antipsychotics from the original dopamine stabilizer aripiprazole

Full article: Efficacy and safety of brexpiprazole as adjunctive treatment in major depressive disorder: overview of four short-term studies

Brexpiprazole in the Treatment of Major Depressive Disorder - Maryam I Al Shirawi, Nicole E Edgar, Sidney H Kennedy, 2017

Brexpiprazole - Mechanism of Action and Clinical Application